Cerca
Cerca
+

European Commission Approves Astellas' XOSPATA™ for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay

default_image

AdnKronos
  • a
  • a
  • a

Dai blog